The Therapeutic Goods Administration recently approved the psychedelic compound psilocybin for treatment-resistant depression; and MDMA–or ecstasy–for treatment-resistant post-traumatic stress disorder. A group of researchers think this is premature.More people are tackling the bracing discomfort…
